TotalMarketCap

Tvardi Therapeutics

TVRDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$11.471 M

$0.86 -0.04%

Close of 6 Nov 2026

As of 6 Nov 2026, Tvardi Therapeutics (TVRD) has a market capitalization of $11.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.14M

#3199 by revenue

Earnings

-$18.2M

Loss-making

Shares outstanding

13,338,943

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #404Dare BioscienceDARE$12.3M
  2. #405BiofronteraBFRI$12.0M
  3. #406Tvardi TherapeuticsTVRD$11.5M
  4. #407AEON BiopharmaAEON$11.3M
  5. #408VyomeHIND$11.3M

What if Tvardi Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,116,875

Per share 2,461,482× higher

Bitcoin $1.53T

$114,540.42

Per share 133,187× higher

Apple $5.02T

$376,025.49

Per share 437,239× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Tvardi Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.